HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase

Cell Death and Disease

Volumn 3, Issue 3, 2012, Pages

  Lecoeur, H ^a   Borgne Sanchez, A ^a,b,c   Chaloin, O ^d   El Khoury, R ^c,e   Brabant, M ^a   Langonne A ^a   Porceddu, M ^b,c   Briere J J ^c,e   Buron, N ^b,c   Rebouillat, D ^a   Pechoux C ^f   Deniaud, A ^g   Brenner, C ^g,h,i   Briand, J P ^d   Muller, S ^d   Rustin, P ^c,e   Jacotot, E ^a,b,c,e,j  

^a INSTITUT PASTEUR   (France)

^b Theraptosis SA   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INRA Institut National de la Recherche Agronomique   (France)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h Universite Paris Sud   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j HAMMERSMITH HOSPITAL   (United Kingdom)

more..

Author keywords

Cytochrome c oxidase; HIV 1; Mitochondria; Tat

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; CYTOCHROME C OXIDASE; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL PERMEABILIZATION; ENZYME INACTIVATION; ENZYME RELEASE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE PERMEABILIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANIMALS; BRAIN; CYTOCHROMES C; ELECTRON TRANSPORT COMPLEX IV; HUMANS; ION TRANSPORT; LIVER; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; PERMEABILITY; PROTO-ONCOGENE PROTEINS C-BCL-2; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84859295755     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.21     Document Type: Article

References (59)

1. Elston T, Wang H, Oster G. Energy transduction in ATP synthase. Nature 1998; 391: 510-513. (Pubitemid 28086555)
2. Noji H, Yoshida M. The rotary machine in the cell, ATP synthase. J Biol Chem 2001; 276: 1665-1668. (Pubitemid 32109632)
3. Briere JJ, Chretien D, Benit P, Rustin P. Respiratory chain defects: what do we know for sure about their consequences in vivo? Biochim Biophys Acta 2004; 1659: 172-177. (Pubitemid 39575504)
4. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. (Pubitemid 46209992)
5. Tait S, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
6. Sugioka R, Shimizu S, Tsujimoto Y. Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem 2004; 279: 52726-52734. (Pubitemid 39656648)
7. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-658. (Pubitemid 40488558)
8. Jourdain A, Martinou JC. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int J Biochem Cell Biol 2009; 41: 1884-1889.
9. Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G. Viral proteins targeting mitochondria: controlling cell death. Biochim Biophys Acta 2004; 1659: 178-189. (Pubitemid 39575505)
10. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008; 4: e1000018.
11. Giacca M. The HIV-1 Tat protein: a multifaceted target for novel therapeutic opportunities. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4: 277-285. (Pubitemid 39445425)
12. Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 2010; 91: 1-12.
13. Noonan D, Albini A. From the outside in: extracellular activities of HIV Tat. Adv Pharmacol 2000; 48: 229-250.
14. Rumbaugh JA, Steiner J, Sacktor N, Nath A. Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. Futur HIV Ther 2008; 2: 271-280.
15. Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res 2009; 16: 205-220.
16. Cantaluppi V, Biancone L, Boccellino M, Doublier S, Benelli R, Carlone S et al. HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res Hum Retroviruses 2001; 17: 965-976. (Pubitemid 32881339)
17. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 1993; 90: 7632-7636. (Pubitemid 23250004)
18. Macho A, Calzado MA, Jiménez-Reina L, Ceballos E, León J, Muñoz E. Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms. Oncogene 1999; 18: 7543-7551. (Pubitemid 30035055)
19. Chen D, Wang M, Zhou S, Zhou Q. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J 2002; 21: 6801-6810. (Pubitemid 36014552)
20. Huo L, Li D, Sun L, Liu M, Shi X, Sun X et al. Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes. J Pathol 2011; 223: 28-36.
21. Norman JP, Perry SW, Kasischke KA, Volsky DJ, Gelbard HA. HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J Immunol 2007; 178: 869-876. (Pubitemid 46095159)
22. Raidel SM, Haase C, Jansen NR, Russ RB, Sutliff RL, Velsor LW et al. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 2002; 282: H1672-1678.
23. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-779. (Pubitemid 24359280)
24. Peloponese Jr JM, Collette Y, Grégoire C, Bailly C, Campèse D, Meurs EF et al. Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J Biol Chem 1999; 274: 11473-11478.
25. Partidos CD, Moreau E, Chaloin O, Tunis M, Briand JP, Desgranges C et al. A synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity. Eur J Immunol 2004; 34: 3723-3731. (Pubitemid 40012190)
26. Partidos CD, Hoebeke J, Moreau E, Chaloin O, Tunis M, Belliard G et al. The binding affinity of double-stranded RNA motifs to HIV-1 Tat protein affects transactivation and the neutralizing capacity of anti-Tat antibodies elicited after intranasal immunization. Eur J Immunol 2005; 35: 1521-1529. (Pubitemid 40691433)
27. Chaloin O, Peter JC, Briand JP, Masquida B, Desgranges C, Muller S et al. The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci 2005; 62: 355-361. (Pubitemid 40379249)
28. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 1998; 187: 1261-1271. (Pubitemid 28189115)
29. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000; 191: 33-46.
30. Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillennec S, Hoebeke J et al. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2. J Exp Med 2001; 193: 509-519. (Pubitemid 32524481)
31. Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M et al. HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One 2008; 3: e3731.
32. Lecoeur H, Langonné A, Baux L, Rebouillat D, Rustin P, Prévost MC et al. Real-time flow cytometry analysis of permeability transition in isolated mitochondria. Exp Cell Res 2004; 294: 106-117. (Pubitemid 38229785)
33. Buron N, Porceddu M, Brabant M, Desgué D, Racoeur C, Lassalle M et al. Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization. PLoS One 2010; 5: e9924.
34. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51. (Pubitemid 24231224)
35. Buccigrossi V, Laudiero G, Nicastro E, Miele E, Esposito F, Guarino A. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism. PLoS One 2011; 6: e29436.
36. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50-54.
37. Cooper CE. Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector? Trends Biochem Sci 2002; 27: 33-39. (Pubitemid 34131623)
38. Yuyama K, Yamamoto H, Nishizaki I, Kato T, Sora I, Yamamoto T. Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res 2003; 73: 351-363. (Pubitemid 36918099)
39. da Silva C, Ribeiro CA, Leipnitz G, Dutra-Filho CS, Wyse AT, Wannmacher CM et al. Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim Biophys Acta 2002; 1586: 81-91. (Pubitemid 34070639)
40. Musatov A, Carroll CA, Liu YC, Henderson GI, Weintraub ST, Robinson NC. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002; 41: 8212-8220. (Pubitemid 34655190)
41. Kiyomiya K, Matsushita N, Kurebe M, Nakagawa H, Matsuo S. Mitochondrial cytochrome c oxidase as a target site for cephalosporin antibiotics in renal epithelial cells (LLC-PK(1)) and renal cortex. Life Sci 2002; 72: 49-57. (Pubitemid 35284553)
42. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41-54. (Pubitemid 36459078)
43. van de Bovenkamp M, Nottet HS, Pereira CF. Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia. Eur J Clin Invest 2002; 32: 619-627. (Pubitemid 36223414)
44. Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 2003; 9: 222-227. (Pubitemid 36656455)
45. Barbaro G. HIV infection, highly active antiretroviral therapy and the cardiovascular system. Cardiovasc Res 2003; 60: 87-95. (Pubitemid 38373479)
46. Haughey NJ, Mattson MP. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 2002; 31 (Suppl 2): S55-S61. (Pubitemid 35190559)
47. Alimonti JB, Ball TB, Fowke KR. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 2003; 84: 1649-1661. (Pubitemid 36805899)
48. Desgranges C, Muller S. HIV-1 Tat and apoptotis death. In: Badley A et al. (eds). Cell Death During HIV Infection, Chap. 9. CRC Press: Boca Raton, FL, 2006, pp 143-148.
49. Strack PR, Frey MW, Rizzo CJ, Cordova B, George HJ, Meade R et al. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci USA 1996; 93: 9571-9576. (Pubitemid 26296649)
50. Nie Z, Bren GD, Rizza SA, Badley AD. HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells. Open Virol J 2008; 2: 1-7.
51. Ferri KF, Jacotot E, Blanco J, Esté JA, Zamzami N, Susin SA et al. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 2000; 192: 1081-1092.
52. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J et al. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 2001; 194: 1097-1110. (Pubitemid 32995780)
53. Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Tintignac LA et al. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 2002; 21: 4070-4080. (Pubitemid 34857439)
54. Perfettini J, Nardacci R, Séror C, Bourouba M, Subra F, Gros L et al. The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope. Cell Death Differ 2009; 16: 298-311.
55. Cummins NW, Badley AD. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 2010; 1: e99.
56. Sims NR, Anderson MF. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nat Protoc 2008; 3: 1228-1239.
57. Wang X, Leverin AL, Han W, Zhu C, Johansson BR, Jacotot E et al. Isolation of brain mitochondria from neonatal mice. J Neurochem 2011; 119: 1253-1261.
58. Neimark J, Briand JP. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept Res 1993; 6: 219-228.
59. Brabant M, Baux L, Casimir R, Briand JP, Chaloin O, Porceddu M et al. A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice. Apoptosis 2009; 14: 1190-1203.